Craig Wilson

Craig Wilson
Professor Emeritus

Professor - Emeritus (P), Epidemiology , School of Public Health 2018 -

Overview

Dr. Craig Wilson joined UAB in 1991 after completing trainings in Pediatrics (Stanford University 1982-1986), Pediatric Infectious Diseases (Harvard University Boston Children’s Hospital 1986-1989) and post-doctoral training in molecular parasitology (Harvard School of Public Health 1987-1991). He had a primary appointment in Pediatrics (Infectious Diseases) and secondary appointments in Medicine (Geographic Medicine), Microbiology and Epidemiology and International Health.

Dr. Craig Wilson joined the School of Public Health in 2007 and served as the Director of the Sparkman Center for Global Health (http://www.sparkmancenter.org) until retiring in 2018. Dr. Wilson had nearly 30 years of experience and expertise in international programs including molecular epidemiology of drug resistance in malaria and HIV prevention and management programs. He had secondary appointments in Pediatrics and Microbiology.

Dr. Wilson had over 20 years of experience in a leadership role in HIV management and prevention in HIV infected and at-risk youth in the US. He was the innaugural Chair and PI of the Adolescent Medicine Trial Network for HIV/AIDS Interventions (ATN) from 2001-2018 and served on the NIH Division of AIDS Strategic Working Group (2006-2016), was appointed to the Office of AIDS Research Advisory Council (2011-2016) and served on the NIH Division of AIDS Youth Prevention Research Working Group 2012-2018 and was the innaugural co-chair. He was on multiple protocol teams testing HIV prevention methods and management strategies in youth and was co-chair for the FDA licensing trials of PrEP in adolescents.

Dr. Wilson has an extensive background in HIV programs in sub-Saharan Africa and provided clinical and laboratory technical assistance to the UAB PEPFAR initiative in Zambia starting in 2004 through the Centre for Infectious Diseases Research in Zambia. He was the UAB PI of the NIH Fogarty International Center funded Medical Education Partnership Initiatives (MEPI) at the University of Zambia and Addis Ababa University from 2011-2016. He is presently working the same two African universities on the continuing Health Professional Education Partnership Initiatives (HEPI) funded from 2018-2023. He has served on many national and international advisory and planning panels for HIV prevention strategies and inclusion of youth in this planning.

Dr Wilson worked on the challenges of lack of textbooks and poor or expensive internet access while working on education programs in Africa for over 10 years. Ultimately working with programmers in Zambia and Ethiopia they developed an open-source software to organize and disseminate educational resources in off-line formats called SparkEd . He is now working closely with collaborators in Ethiopia and the Ministry of Education to disseminate resources developed for Secondary Schools in Ethiopia (http://www.sparkmancenter.org) .

Selected Publications

Academic Article

Year	Title	Altmetric
2020	Changes in Bone Mass after Discontinuation of Preexposure Prophylaxis with Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex with Men: Extension Phase Results of Adolescent Trials Network Protocols 110 and 113 2020
2020	Brief Report: Phase IIa Safety Study of a Vaginal Ring Containing Dapivirine in Adolescent Young Women 2020
2020	Prior incarceration associated with missed HIV care visits among young people living with HIV in the US^* 2020
2020	Transmission Risk Among Youth Living With HIV in the U.S. 2020
2019	Stiff as a board: Measuring rigor mortis in Zebrafish 2019
2019	Why Zebrafish? 2019
2019	You are what you eat 2019
2019	Predictors of smoking cessation among people living with HIV receiving routine clinical care 2019
2019	Mental health disorders and alcohol use are associated with increased likelihood of smoking relapse among people living with HIV attending routine clinical care 2019
2019	Pre-vaccination prevalence of anogenital and oral human papillomavirus in young HIV-infected men who have sex with men 2019
2019	A measure to assess HIV treatment readiness among adolescents and young adults 2019
2019	Role of sociobehavioral factors in subprotective TFV-DP Levels among YMSM Enrolled in 2 PrEP Trials 2019
2019	Short Communication: Association of Vitamin D Insufficiency and Protective Tenofovir Diphosphate Concentrations with Bone Toxicity in Adolescent Boys and Young Men Using Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Pre-Exposure Prophylaxis 2019
2018	Enzymes of pyrimidine salvage pathways in intraerythrocytic Plasmodium falciparum 2018
2018	Correlates of Serodiscordant Condomless Anal Intercourse Among Virologically Detectable HIV-Positive Young Men Who Have Sex with Men 2018
2018	A cross-sectional study examining associations between substance use frequency, problematic use and STIs among youth living with HIV 2018
2018	HIV-Infected Young Men Demonstrate Appropriate Risk Perceptions and Beliefs about Safer Sexual Behaviors after Human Papillomavirus Vaccination 2018
2018	Tobacco Use and Sustained Viral Suppression in Youth Living with HIV 2018
2018	In reply 2018
2018	Linking HIV-Negative Youth to Prevention Services in 12 U.S. Cities: Barriers and Facilitators to Implementing the HIV Prevention Continuum 2018
2018	Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis among Adolescent and Young Men Who Have Sex with Men in the United States 2018
2018	Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults with Human Immunodeficiency Virus Infection Being Treated with Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial 2018
2018	HIV Continuum of Care for Youth in the United States 2018
2018	Partner Notification for Youth Living With HIV in 14 Cities in the United States 2018
2018	Tenofovir disoproxil fumarate appears to disrupt the relationship of Vitamin D and parathyroid hormone 2018
2017	Safety and feasibility of antiretroviral preexposure prophylaxis for adolescent men who have sex with men aged 15 to 17 years in the United States 2017
2017	Implementation of an integrated approach to the national HIV/AIDS strategy for improving human immunodeficiency virus care for youths 2017
2017	Strengthening and expanding the capacity of health worker education in Zambia 2017
2017	Evaluating testing strategies for identifying youths with HIV infection and linking youths to biomedical and other prevention services 2017
2017	An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM 2017
2017	Decline in bone mass with tenofovir disoproxil fumarate/emtricitabine is associated with hormonal changes in the absence of renal impairment when used by HIV-uninfected adolescent boys and young men for HIV preexposure prophylaxis 2017
2016	Emtricitabine-Triphosphate in dried blood spots as a marker of recent dosing 2016
2016	Preventing HIV among adolescents with oral PrEP: Observations and challenges in the United States and South Africa 2016
2016	Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV 2016
2016	Sexual risk behavior among virologically detectable human immunodeficiency virus-infected young men who have sex with men 2016
2015	Factors Associated With Smoking Status among HIV-Positive Patients in Routine Clinical Care. 2015
2015	Immune reconstitution but persistent activation after 48 weeks of antiretroviral therapy in youth with pre-therapy CD4 >350 in ATN 061 2015
2015	How we implemented an analytical support clinic to strengthen student research capacity in Zambia 2015
2015	Mitochondrial DNA diversity in the African American population 2015
2015	Rates and correlates of antiretroviral therapy use and virologic suppression among perinatally and behaviorally HIV-infected youth linked to care in the United States 2015
2014	Mitochondrial DNA variation and virologic and immunological HIV outcomes in African Americans 2014
2014	KIR2DS4 promotes HIV-1 pathogenesis: New evidence from analyses of immunogenetic data and natural killer cell function 2014
2014	How we implemented an analytic support clinic to strengthen student research capacity in Zambia 2014
2014	Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate 2014
2013	Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: Fine-mapping for the GC/DBP gene that encodes the vitamin D-binding protein 2013
2013	Association of higher plasma vitamin d binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: Cause of a functional Vitamin D deficiency? 2013
2013	Variants in interleukin family of cytokines genes influence clearance of high risk HPV in HIV-1 coinfected African-American adolescents 2013
2013	Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women 2013
2013	Incident anal human papillomavirus and human papillomavirus-related sequelae in HIV-infected versus HIV-uninfected adolescents in the United States 2013
2013	Incidence of sexually transmitted infections in HIV-infected and HIV-uninfected adolescents in the USA 2013
2013	Body condition scoring for Laboratory Zebrafish 2013
2013	The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men 2013
2013	Assessment of biomarkers of cardiovascular risk among HIV type 1-infected adolescents: Role of soluble vascular cell adhesion molecule as an early indicator of endothelial inflammation 2013
2013	Comprehension of a simplified assent form in a vaccine trial for adolescents 2013
2013	Oral Lesions: Poor Markers of Virologic Failure in HIV-Infected Patients on Antiretroviral Therapy 2013
2012	Aspects of larval rearing 2012
2012	Prevalence of proteinuria and elevated serum cystatin c among hiv-infected adolescents in the reaching for Excellence in Adolescent Care and Health (REACH) study 2012
2012	Toll-like receptor gene variants associated with bacterial vaginosis among HIV-1 infected adolescents 2012
2012	Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection 2012
2012	Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent trials network study 021B 2012
2012	Incidence, prevalence, and epidemiology of herpes simplex virus-2 in HIV-1-positive and HIV-1-negative adolescents 2012
2012	Substantial multiclass transmitted drug resistance and drug-relevant polymorphisms among treatment-naïve behaviorally HIV-infected youth 2012
2012	Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: A randomized, placebo-controlled trial 2012
2012	Transitional probability-based model for HPV clearance in HIV-1-positive adolescent females 2012
2012	Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination. 2012
2011	Contemporary profile of oral manifestations of HIV/AIDS and associated risk factors in a southeastern US clinic 2011
2011	Prevalence, incidence, and recurrence of oral lesions among HIV-infected patients on HAART in Alabama: A two-year longitudinal study 2011
2011	Sex ratio bias and embryo production in Zebrafish housed in 10 litre aquaria 2011
2011	Identification of three immunologic correlates for HIV type 1 pathogenesis in Youth 2011
2011	Hepatitis B vaccination in HIV-infected youth: A randomized trial of three regimens 2011
2011	The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African Americans 2011
2011	Hormonal contraceptive use and response to antiretroviral therapy among adolescent females 2011
2011	The Zambian HIV Nurse practitioner diploma program: Preliminary outcomes from first cohort of Zambian Nurses 2011
2010	Interleukin-10 (IL-10) pathway: Genetic variants and outcomes of HIV-1 infection in African American adolescents 2010
2010	Association between Anemia and Aflatoxin B-1 Biomarker Levels among Pregnant Women in Kumasi, Ghana 2010
2010	The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents 2010
2010	Epidemiology of HIV infection and risk in adolescents and youth 2010
2010	Human leukocyte antigen class I supertypes and HIV-1 control in African Americans 2010
2010	Association between birth outcomes and aflatoxin B1 biomarker blood levels in pregnant women in Kumasi, Ghana 2010
2010	Demographic Profiles of Newly Acquired HIV Infections Among Adolescents and Young Adults in the U.S. 2010
2010	Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent trials network study 021 2010
2010	Randomized trial to determine safety and immunogenicity of two strategies for hepatitis B vaccination in healthy Urban adolescents in the United States 2010
2009	Predictors of suboptimal virologic response to highly active antiretroviral therapy among human immunodeficiency virus-infected adolescents: Analyses of the Reaching for Excellence in Adolescent Care and Health (REACH) Project 2009
2009	Clear and independent associations of several HLA-DRB1 alleles with diVerential antibody responses to hepatitis B vaccination in youth 2009
2009	Short-cycle therapy in adolescents after continuous therapy with established viral suppression: The impact on viral load suppression 2009
2009	Host genetics and HIV-1 viral load set-point in African-Americans 2009
2008	Immunogenetic correlates of neisseria gonorrhoeae infection in adolescents 2008
2008	Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection 2008
2008	Inclusion of adolescents in preventive HIV vaccine trials: Public health policy and research design at a crossroads 2008
2007	Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents 2007
2007	Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia 2007
2007	HIV voluntary counseling and testing among injection drug users in south China: A study of a non-government organization based program 2007
2007	Interleukin-10 gene (IL10) polymorphisms and human papillomavirus clearance among immunosuppressed adolescents 2007
2007	Calibration and validation of an oral fluid-based sensitive/less-sensitive assay to distinguish recent from established HIV-1 infections 2007
2007	CCL3L1 and CCL4L1: Variable gene copy number in adolescents with and without human immunodeficiency virus type 1 (HIV-1) infection 2007
2007	Glutathione, glutathione peroxidase, and selenium status in HIV-positive and HIV-negative adolescents and young adults 2007
2006	Prevalence of primary HIV-1 drug resistance among recently infected adolescents: A Multicenter Adolescent Medicine Trials Network for HIV/AIDS Interventions Study 2006
2006	Cohort- and time-specific associations of CTLA4 genotypes with HIV-1 disease progression 2006
2006	HIV-1 epitope-specific CD8⁺ T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently 2006
2006	Vitamin D status in adolescents and young adults with HIV infection 2006
2006	Interleukin 18 and human immunodeficiency virus type I infection in adolescents and adults 2006
2006	Vitamins C and E in adolescents and young adults with HIV infection 2006
2006	Immune reconstitution and predictors of virologic failure in adolescents infected through risk behaviors and initiating HAART: Week 60 results from the PACTG 381 cohort 2006
2006	Group M-based HIV-1 Gag peptides are frequently targeted by T cells in chronically infected US and Zambian patients 2006
2005	Interleukin (IL)-2 and IL-12 responses to Chlamydia trachomatis infection in adolescents 2005
2005	Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus 2005
2005	Plasma cytokines and oxidative damage in HIV-positive and HIV-negative adolescents and young adults: A protective role for IL-10? 2005
2005	Human leukocyte antigen and cytokine gene variants as predictors of recurrent Chlamydia trachomatis infection in high-risk adolescents 2005
2005	CD8 T-cell responses in early HIV-1 infection are skewed towards high entropy peptides 2005
2005	Immune activation and oxidative damage in HIV-positive and HIV-negative adolescents 2005
2004	Epidemiological and genetic correlates of incident Chlamydia trachomatis infection in North American adolescents 2004
2004	HIV-infected US youth are at high risk of obesity and poor diet quality: A challenge for improving short- and long-term health outcomes 2004
2004	US youths in the early stages of HIV disease have low intakes of some micronutrients important for optimal immune function 2004
2004	Erratum: CD8⁺ CD38⁺ T cells but not HIV type 1 RNA viral load predict CD4⁺ cell loss in a predominantly minority female HIV⁺ adolescent population (AIDS Research and Human Retroviruses (2004) 22 (263-269)) 2004
2004	Cytokine and Chemokine Gene Polymorphisms among Ethnically Diverse North Americans with HIV-1 Infection 2004
2004	HLA and Cytokine Gene Polymorphisms Are independently Associated with Responses to Hepatitis B Vaccination 2004
2004	CD8⁺CD88⁺ T cells but not HIV type 1 RNA viral load predict CD4⁺ T cell loss in a predominantly minority female HIV ⁺ adolescent population 2004
2004	Tolerance and Safety of Different Concentrations of Chlorhexidine for Peripartum Vaginal and Infant Washes: HIVNET 025 2004
2003	T Cell Responses in HIV Type 1-Infected Adolescent Minorities Share Similar Epitope Specificities with Whites Despite Significant Differences in HLA Class I Alleles 2003
2003	Cross-reactive CD8⁺ T cell epitopes identified in US adolescent minorities 2003
2003	CD4⁺ and CD8⁺ T cell receptor repertoire perturbations with normal levels of T cell receptor excision circles in HIV-infected, therapy-naive adolescents 2003
2003	TH1 and TH2 cytokine mRNA and protein levels in human immunodeficiency virus (HIV)-seropositive and HIV-seronegative youths 2003
2003	Delayed onset of pubertal development in children and adolescents with perinatally acquired HIV infection 2003
2003	The relationships between substance abuse, psychosocial variables, and natural killer cell enumeration and function in HIV-infected and high-risk uninfected adolescents 2003
2003	Assessment of thymic activity in human immunodeficiency virus-negative and -positive adolescents by real-time PCR quantitation of T-cell receptor rearrangement excision circles 2003
2003	Barriers to HAART adherence among human immunodeficiency virus - Infected adolescents 2003
2003	Human papillomavirus infection and abnormal cytology of the anus in HIV-infected and uninfected adolescents 2003
2002	Increased proliferation within T lymphocyte subsets of HIV-infected adolescents 2002
2002	Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents 2002
2002	Barriers to HIV testing - Where next? 2002
2002	Peripheral blood lymphocyte subsets in adolescents: A longitudinal analysis from the REACH project 2002
2002	CCR2 and CCR5 genotypes in HIV type 1-infected adolescents: Limited contributions to variability in plasma HIV type 1 RNA concentration in the absence of antiretroviral therapy 2002
2001	HIV-related oral manifestations among adolescents in a multicenter cohort study 2001
2001	Douching practices among HIV infected and uninfected adolescents in the United States 2001
2001	Serologic response to hepatitis B vaccine in HIV infected and high-risk HIV uninfected adolescents in the REACH cohort 2001
2001	Sexually transmitted infections among HIV infected and HIV uninfected high-risk youth in the REACH study 2001
2001	The REACH (Reaching for Excellence in Adolescent Care and Health) project: Study design, methods, and population profile 2001
2001	Performance of antigens used in detecting delayed-type hypersensitivity in adolescents infected with the human immunodeficiency virus 2001
2001	Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA 2001
2001	Natural killer cell enumeration and function in HIV-infected and high-risk uninfected adolescents 2001
2000	Marijuana use among HIV-positive and high-risk adolescents: A comparison of self-report through audio computer-assisted self-administered interviewing and urinalysis 2000
2000	Erratum: T-lymphocyte subsets in HIV-infected and high-risk HIV-uninfected adolescents: Retention of naive T lymphocytes in HIV-infected adolescents (Archives (2000) 154 (375-380)) 2000
2000	Relationship of CD4⁺ T cell counts and HIV type 1 viral loads in untreated, infected adolescents 2000
2000	Pinworm (Enterobius vermicularis) 2000
2000	Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: Impact of infection with human immunodeficiency virus 2000
2000	Seroprevalence and risk factors of hepatitis B, hepatitis C, and human cytomegalovirus among HIV-infected and high-risk uninfected adolescents: Findings of the reach study 2000
2000	T-lymphocyte subsets in HIV-infected and high-risk HIV-uninfected adolescents: Retention of naive T lymphocytes in HIV-infected adolescents 2000
2000	The prevalence of anergy in Human Immunodeficiency Virus-infected adolescents and the association of delayed-type hypersensitivity with subject characteristics 2000
1999	The adenosine transporter of Toxoplasma gondii. Identification by insertional mutagenesis, cloning, and recombinant expression 1999
1999	Insertional tagging of at least two loci associated with resistance to adenine arabinoside in Toxoplasma gondii, and cloning of the adenosine kinase locus 1999
1999	Peripheral blood mononuclear cell markers in antiretroviral therapy-naive HIV-infected and high risk seronegative adolescents 1999
1998	The REACH Project of the Adolescent Medicine HIV/AIDS Research Network: Design, methods, and selected characteristics of participants 1998
1997	Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum 1997
1996	Molecular characterization of airport malaria 1996
1996	Characterization of the δ-aminolevulinate synthase gene homologue in P. falciparum 1996
1996	Erratum: Characterization of the δ-aminolevulinate synthase gene homologue in P. falciparum (Molecular and Biochemical Parasitology 75 (1996) (271-276)) 1996
1996	Plasmodium falciparum: Molecular characterization of multidrug-resistant Cambodian isolates 1996
1995	Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from Subsaharan Africa 1995
1995	Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum 1995
1994	Characterization of the pfmdr2 gene for Plasmodium falciparum 1994
1994	Respiratory distress caused by parasites. 1994
1993	Cross-reactivity between Stomatococcus mucilaginosus and latex agglutination for cryptococcal antigen 1993
1993	Amplification of pfmdr1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand 1993
1993	Characterization of the pfmdr 2 gene for Plasmodium falciparum 1993
1993	Stage-specific transcripts of the Plasmodium falciparum pfmdr1 gene 1993
1993	The dihydroorotate dehydrogenase gene homologue of Plasmodium falciparum 1993
1991	Successful treatment of disseminated Fusarium infection after autologous bone marrow transplantation for acute myeloid leukemia 1991
1990	Scedosporium inflatum: Clinical spectrum of a newly recognized pathogen 1990
1989	A concurrent epidemic of respiratory syncytial virus and echovirus 7 infections in an intensive care nursery 1989
1989	Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum 1989
1987	A technique for the administration of ribavirin to mechanically ventilated infants with severe respiratory syncytial virus infection 1987

Chapter

Year	Title	Altmetric
2015	Giardiasis 2015
2015	Pinworm Infestations 2015
2012	Antiparasitic Agents. 1518-1545.e3. 2012

Research Overview

Dr. Wilson’s early research focused on the molecular epidemiology of drug resistance in malaria parasites including the first identification of mdr-like genes in malaria (1989). Dr. Wilson’s lab at UAB was involved in the molecular identification and characterization of the first nutrient transporter characterized in any protozoan parasite (1999). Dr Wilson also was the first to describe the clinical presentations of a newly identified fungal pathogen in humans (1990).
Dr. Wilson began to work on the challenges of HIV prevention and management in youth in 1996 and continued this work through his retirement. He was PI of the Data and Operations Center for the REACH project (1996-2003) and Innaugural Chair of the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) from 2001-2018. His collaborative work within these networks resulted in over 120 personal peer reviewed manuscripts and over 300 total publications.

Dr. Wilson has had a leadership and advisory role on issues related to HIV in adolescents, trials and approaches to studies in adolescents and vulnerable populations and biomedical trials in developing countries. In this regard, he served on the NIH Office of AIDS Research Advisory Council from 2011-2016, NIH Division of AIDS Strategic Working Group from 2006–2016, on World Health Organization (WHO) panel on the ethics of vaccine trials in developing countries in 2002 and other international panels on HIV prevention trials in developing countries, and on NIH advisory and review panels on the domestic adolescent HIV research agenda and its implementation

Principal Investigator On

ATN Coordinating Center awarded by National Institute of Child Health and Human Development/NIH/DHHS 2011 - 2018

Medical Education Partnership Initiative for Ethiopia (MEPI) awarded by ADDIS ABABA UNIVERSITY 2015 - 2016

Programmatic Expanding Innovative Multidisciplinary Medical Education in Zambia awarded by UNIVERSITY OF ZAMBIA 2010 - 2015

Medical Education Partnership Initiative for Ethiopia (MEPI) awarded by ADDIS ABABA UNIVERSITY 2014 - 2015

Zambian Educational Partnership for Advanced Care and Training (ZEPACT) awarded by UNIVERSITY OF ZAMBIA 2011 - 2014

Medical Education Partnership Initiative for Ethiopia (MEPI) awarded by ADDIS ABABA UNIVERSITY 2013 - 2014

Medical Education Partnership Initiative for Ethiopia (MEPI) awarded by ADDIS ABABA UNIVERSITY 2012 - 2013

ATN Coordinating Center awarded by National Institute of Child Health and Human Development/NIH/DHHS 2006 - 2012

Investigator On

Health Professionals Education Partnership Initiative (HEPI) awarded by ADDIS ABABA UNIVERSITY 2018 - 2019

Using Respondent Driven Sampling (RDS) to Complete Size Estimations of Men who have Sex with Men (MSM) and Trans- Populations in Belize awarded by CARIBBEAN VULNERABLE COMMUNITIES COALITION (CVC) 2017 - 2018

Teaching Overview

Dr. Wilson directed the establishment of the UAB School of Public Health Graduate Certificate in Global Health in 2009 and the establishment of the Global Health Concentration in the Public Health major in 2014. Dr. Wilson worked closely with the School of Public Health leadership to establish and develop the Public Health undergraduate major.
Dr. Wilson taught graduate and undergraduate courses in Global Health and Global Infectious Diseases and lectured in many courses on infectious diseases related topics including HIV and HPV.